ICP-332 in Subjects With Non-segmental Vitiligo - Clinical Trial NCTNCT07047612

Business Opportunities for NCT07047612

Connect with principal investigators, study coordinators, and key decision makers for this PHASE2, PHASE3 trial studying investigational therapy for Non Segmental Vitiligo.

Clinical Trial Information

Study Sponsor
Sponsor information available
Drug/Intervention
Study intervention details available
Therapeutic Area
Therapeutic area information available
Study Phase
PHASE2, PHASE3
Study Status
RECRUITING
NCT Number
NCTNCT07047612

Find Contact Information

Access exclusive contact details for:

  • Principal investigators and sub-investigators
  • Study coordinators and research staff
  • Site directors and facility contacts
  • Sponsor representatives and CRO partners
  • Business development professionals
  • Clinical operations managers

Clinical Trial Locations

This study has 33 locations across China.

Study Site

Wuhu, Anhui China

Study Site

Beijing, Beijing China

Study Site

Chongqing, Chongqing China

Study Site

Chongqing, Chongqing China

Study Site

Fuzhou, Fujian China

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships